Therapeutic use of the high-density lipoprotein protein and peptides

Expert Opinion on Investigational Drugs
Marta Marchesi, Cesare R Sirtori

Abstract

High-density lipoprotein (HDL) therapy is a novel and emerging area of therapeutic development in the cardiovascular field. It attempts to supplement and improve the vascular benefit exerted by other agents that are active on lipid metabolism, for example, hypolipidaemic drugs. Furthermore, it takes advantage of the novel techniques of coronary evaluation. A number of reports have examined the potential therapeutic properties of the synthetic HDLs prepared by complexing recombinant apolipoprotein (apo) A-I(Milano), a variant form of native apoA-I, with phospholipids. The availability of synthetic HDL complexes containing recombinant apoA-I(Milano) has opened up a new era of therapeutic management for coronary disease. HDL formulations of recombinant apoA-I(Milano)-phospholipid complexes have clearly shown rapid regression of a focal carotid atheroma as well as powerful protection from myocardial infarction in a rabbit model. In a pilot study, ETC-216 showed a significant reduction in coronary plaque burden after five weekly treatments, assessed by intravascular ultrasound in patients with acute coronary syndrome. Other therapeutic options of HDL therapy have recently became available.

References

Jun 1, 1991·The Journal of Clinical Investigation·G AmbrosioM Chiariello
Jun 1, 1991·Atherosclerosis·G FranceschiniC R Sirtori
Mar 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·J L ZweierM L Weisfeldt
May 28, 1987·The New England Journal of Medicine·S GlagovG J Kolettis
Nov 28, 1986·JAMA : the Journal of the American Medical Association·W P CastelliW B Kannel
Apr 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·S M Grundy, D W Bilheimer
Sep 28, 1995·The American Journal of Cardiology·R P ByingtonM G Bond
Nov 1, 1995·Arteriosclerosis, Thrombosis, and Vascular Biology·G W CockerillP J Barter
Mar 10, 1995·The Journal of Biological Chemistry·H H SchmidtJ M Hoeg
Sep 1, 1996·Arteriosclerosis, Thrombosis, and Vascular Biology·M N NanjeeN E Miller
Nov 26, 1996·Proceedings of the National Academy of Sciences of the United States of America·W S DavidsonA Jonas
Mar 1, 1997·Clinical and Experimental Pharmacology & Physiology·P J Barter
Sep 23, 1997·Biochemical and Biophysical Research Communications·L CalabresiD Taramelli
Feb 12, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·D LiJ L Mehta
Apr 9, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·M N NanjeeN E Miller
May 14, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·G FranceschiniF Bernini
Jul 17, 1999·Atherosclerosis·O Stein, Y Stein
Dec 10, 1999·The Annals of Thoracic Surgery·J L Park, B R Lucchesi
Sep 29, 2000·The American Journal of Cardiology·H B Rubins, S J Robins
Apr 13, 2001·JAMA : the Journal of the American Medical Association·G G SchwartzUNKNOWN Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators

❮ Previous
Next ❯

Citations

Oct 23, 2008·Expert Review of Cardiovascular Therapy·Alan T RemaleyDmitri Sviridov
Mar 6, 2008·Expert Opinion on Drug Delivery·Robert O Ryan
May 15, 2012·Biotechnology Journal·Tatsuya Murakami
Sep 12, 2006·Free Radical Biology & Medicine·Anne Negre-SalvayreRobert Salvayre
Feb 23, 2011·Arquivos brasileiros de endocrinologia e metabologia·Camila Canteiro LeançaEder C R Quintão
May 27, 2020·Current Opinion in Cardiology·Ahmed HandhleAnthony S Wierzbicki

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Related Papers

Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
Paola Conca, Guido Franceschini
The American Journal of Cardiology
James S Forrester, Prediman K Shah
© 2021 Meta ULC. All rights reserved